Skip to main content

Siemens Healthcare launch new 7 Tesla MRI research system

academics

 

Clinical research courses

Siemens Healthcare planning to introduce the Magnetom Terra 7 Tesla MRI system to convert cutting-edge MRI research results into clinical application. This translation will allow user in less than ten minutes.  New 7 Tesla MRI system provides the whole range of cutting-edge 7 Tesla research functionalities, and is based on the latest software platform syngo MR E11, identical to Siemens’ latest flagship 3 Tesla MRI systems, to enable consistent usability and protocol exchange. It is the world’s first ultra-high field research system ready for future clinical use with planned CE and FDA authorization to market for selected neurological and musculoskeletal MR imaging applications.

MAGNETOM Terra1 comes equipped with the latest ultra-high-field technological features, aiding you in obtaining excellent image quality to support your 7T MRI clinical and research endeavors.New actively shielded magnet is the lightest 7 Tesla whole body magnet in the world – 50 per cent lighter than previous actively shielded 7 Tesla magnet generations. This is the result of a multi-year engineering project at Siemens Magnet Technologies in Oxford, capitalizing on the long-term experience of the team in the design and manufacturing of state-of-the-art 3 Tesla magnets for clinical use. As a result, with Magnetom Terra, siting of a 7 Tesla MRI system becomes much easier and its location in a clinical environment becomes feasible. Combined with the Zero Helium boil-off technology, Magnetom Terra improves the lifecycle costs of ultra-high field MRI.

MAGNETOM Terra’s improved workflow and Quiet Suite, help you improve patient and/or volunteer experience.This specially designed 7 Tesla technology makes this possible by offering up to eight channel parallel transmit technology for selective excitation and higher homogeneity in challenging body regions such as cardiac and abdominal.


<< Pharma News

Subscribe to PharmaTutor News Alerts by Email >>